WallStreetZenWallStreetZen

NYSEMKT: VNRX
Volitionrx Ltd Stock

$1.01+0.02 (+2.02%)
Updated Feb 28, 2024
VNRX Price
$1.01
Fair Value Price
N/A
Market Cap
$79.47M
52 Week Low
$0.55
52 Week High
$2.10
P/E
-1.91x
P/B
-38.9x
P/S
82.74x
PEG
N/A
Dividend Yield
N/A
Revenue
$651.04k
Earnings
-$33.86M
Gross Margin
100%
Operating Margin
-5,167.4%
Profit Margin
-5,201.3%
Debt to Equity
-10.23
Operating Cash Flow
-$30M
Beta
0.98
Next Earnings
Mar 13, 2024
Ex-Dividend
N/A
Next Dividend
N/A

VNRX Overview

VolitionRX Ltd. is a multi-national life sciences company, which engages in the development of blood-based cancer tests to help diagnose a range of cancers. The company is headquartered in Austin, Texas and currently employs 44 full-time employees. The firm is focused on developing blood-based diagnostic tests for detecting and diagnosing cancer and other diseases. The firm has developed approximately 30 blood-based assays to detect specific biomarkers that can be used individually or in combination to generate a profile, which forms the basis of a test for a particular cancer or disease. The firm's Nucleosomics biomarker platform is a technology that is used for a range of cancers. The firm is developing Nucleosomics tests for various cancers, including colorectal, pancreatic, lung and aggressive prostate. The firm's NuQ blood assays fall into over five types, which include NuQ-X, NuQ-V, NuQ-M, NuQ-A and NuQ-T. The company has developed approximately two blood assays in the NuQ-X family to detect the presence of cancer by detecting nucleosomes containing specific nucleotides.

Zen Score

Industry Average (27)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how VNRX scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

VNRX is unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
VNRX is unprofitable, so we are unable to assess its PEG ratio
PEG Value Valuation
VNRX's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
There are 30 more VNRX due diligence checks available for Premium users.

Be the first to know about important VNRX news, forecast changes, insider trades & much more!

Valuation

VNRX price to earnings (PE)

For valuing profitable companies with steady earnings
Company
-1.91x
Industry
40.18x
Market
35.52x

VNRX price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
-38.9x
Industry
4.33x

VNRX's financial health

Profit margin

Revenue
$165.2k
Net Income
-$8.4M
Profit Margin
-5,066.4%
VNRX's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
VNRX's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$18.0M
Liabilities
$20.9M
Debt to equity
-10.23
VNRX's short-term liabilities ($17.65M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
VNRX's short-term assets ($12.20M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
VNRX's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
VNRX's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$8.4M
Investing
-$273.0k
Financing
-$274.8k
VNRX's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

VNRX vs Diagnostic & Research Stocks

TickerMarket Cap1d %P/EP/B
VNRX$79.47M+2.02%-1.91x-38.90x
ACRS$84.40M-0.83%-0.94x0.54x
BNR$85.34M+3.99%-0.86x0.70x
PRPH$85.53M-5.77%-7.52x1.52x
STIM$85.93M-8.62%-2.52x2.26x

Volitionrx Stock FAQ

What is Volitionrx's quote symbol?

(NYSEMKT: VNRX) Volitionrx trades on the NYSEMKT under the ticker symbol VNRX. Volitionrx stock quotes can also be displayed as NYSEMKT: VNRX.

If you're new to stock investing, here's how to buy Volitionrx stock.

What is the 52 week high and low for Volitionrx (NYSEMKT: VNRX)?

(NYSEMKT: VNRX) Volitionrx's 52-week high was $2.10, and its 52-week low was $0.55. It is currently -51.9% from its 52-week high and 83.64% from its 52-week low.

How much is Volitionrx stock worth today?

(NYSEMKT: VNRX) Volitionrx currently has 78,685,873 outstanding shares. With Volitionrx stock trading at $1.01 per share, the total value of Volitionrx stock (market capitalization) is $79.47M.

Volitionrx stock was originally listed at a price of $3.00 in Mar 2, 2012. If you had invested in Volitionrx stock at $3.00, your return over the last 11 years would have been -66.33%, for an annualized return of -9.42% (not including any dividends or dividend reinvestments).

How much is Volitionrx's stock price per share?

(NYSEMKT: VNRX) Volitionrx stock price per share is $1.01 today (as of Feb 28, 2024).

What is Volitionrx's Market Cap?

(NYSEMKT: VNRX) Volitionrx's market cap is $79.47M, as of Feb 29, 2024.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Volitionrx's market cap is calculated by multiplying VNRX's current stock price of $1.01 by VNRX's total outstanding shares of 78,685,873.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.